Abstract:Interactions between the gut microbiota and host immunity are sophisticated, dynamic, and host-dependent. Scientists have recently conducted research showing that disturbances in the gut bacterial community can lead to a decrease in some metabolites and, consequently, to behaviors such as depression. Exposure to stressors dropped the relative abundance of bacteria in the genus Bacteroides while soaring the relative abundance of bacteria in the genus Clostridium, Coprococcus, Dialister, and Oscillibacter, which were also reduced in people with depression. Microbiota and innate immunity are in a bilateral relationship. The gut microbiota has been shown to induce the synthesis of antimicrobial proteins such as catalysidins, type C lectins, and defensins. Probiotic bacteria can modulate depressive behavior through GABA signaling. The gut microbiome produces essential metabolites such as neurotransmitters, tryptophan metabolites, and short-chain fatty acids (SCFAs) that can act on the CNS. In the case of dysbiosis, due to mucin changes, the ratio of intestinal-derived molecules may change and contribute to depression. Psychotropics, including Bifidobacterium longum NCC3001, Clostridium butyricum CBM588, and Lactobacillus acidophilus, have mental health benefits, and can have a positive effect on the host-brain relationship, and have antidepressant effects. This article reviews current studies on the association between gut microbiota dysbiosis and depression. Comprehensively, these findings could potentially lead to novel approaches to improving depressive symptoms via gut microbiota alterations, including probiotics, prebiotics, and fecal microbiota transplantation.

Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression

Mood and Microbes: a Comprehensive Review of Intestinal Microbiota’s Impact on Depression

Epigenetics in depression and gut-brain axis: A molecular crosstalk

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

Gut Microbial Clues to Bipolar Disorder: State‐of‐the‐art Review of Current Findings and Future Directions

Gut-brain axis: A matter of concern in neuropsychiatric disorders ...!

Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review

Updated Review of Research on the Gut Microbiota and Their Relation to Depression in Animals and Human Beings

Depression-associated gut microbes, metabolites and clinical trials

Potential role of gut microbiota in major depressive disorder: A review

The microbiota-gut-brain axis in pathogenesis of depression: a narrative review

Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications

The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder

Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies

The Gut-Brain Axis and Its Role in Depression

Gut-to-brain axis provides novel therapeutic targets for depression

“I Am I and My Bacterial Circumstances”: Linking Gut Microbiome, Neurodevelopment, and Depression

The Microbiota-Gut-Brain Axis: A New Direction in Research on Depression

The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect

Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime

The Role of Microbiota in Depression - a brief review